Clinical signs: polyphagia, polyuria/polydipsia, pyoderma, pot-bellied appearance, urinary tract, and infection
1. Hyperadrenocorticism
a. Middle-older aged dogs
b. Clinical Signs
i. Polyphagia
ii. Polyuria/polydipsia
iii. Pyoderma
iv. Pot bellied appearance
v. Urinary tract infection
c. Physical examination
i. Hepatomegaly
ii. truncal obesity
iii. muscle wasting
iv. panting
v. bilaterally symmetrical alopecia
vi. thin, hyperpigmented skin
vii. Calcinosis cutis
viii. Lipid deposits
d. Hyperadrenocorticism-CBC changes
i. Erythrocytosis
ii. neutrophilia with a left shift
iii. stress leukogram
iv. mature neutrophilia
v. monocytosis
vi. eosinopenia
vii. lymphopenia
e. Hyperadrenocorticism-Chemistry changes
i. hyperglycemia (mild)
ii. elevated Les
iii. elevated cholesterol
iv. lipemia
f. Urinalysis
i. low specific gravity
ii. sediment: rbc's, wbc's, bacteria - UTI
g. Hyperadrenocorticism – etiology
i. Adrenal tumors (15%)
ii. Pituitary tumors (85%)
iii. Both produce an excess of cortisol that causes disease
h. Hyperadrenocorticism – diagnosis
i. Low Dose Dexamethasone Suppression Test
1. Sensitivity (89-92%)
2. Specificity (75%)
3. Least specific in animals with concurrent disease
4. Measure cortisol
ii. ACTH Stimulation Test
1. Less sensitive (75-83%)
2. Specificity (85%)
3. More specific in animals with concurrent disease
4. Differentiating Pituitary and Adrenal Disease
5. Measure cortisol and aldosterone
iii. Urine Cortisol:Creatinine
1. Very sensitive (100%)
2. Not specific
3. First morning urine
4. 3 days in a row
5. All normal
6. Rule out HAC
i. Treatment
i. Trilostane versus lydosren
ii. Surgery
iii. Ketoconazole
iv. Deprenyl (Anipryl)
j. Treatment considerations
i. Cost of treatment
ii. Neurologic disease
iii. Time of resolution of signs
iv. Owner frustration
k. Treatment Pituitary vs Adrenal
i. Endogenous ACTH concentration
1. adrenal tumors <10 pg/ml
2. PDH: high
3. PDH: overlap with normal
ii. Abdominal ultrasound
1. adrenal tumor
2. bilateral adrenal hyperplasia
l. Treatment-PDH
i. o,p'-DDD (Lysodren)
ii. Trilostane (vetoryl)
iii. Deprenyl (anipryl)
iv. Ketoconazole
m. Treatment – adrenal tumors
i. Surgery
ii. Trilostane
iii. Lysodren
iv. Trilostane + Lysodren
v. ketoconazole
n. Lysodren
i. DDT derivative
ii. Kills adrenocortical cells
iii. Preference for the cortisol producing ones (Fasciculata and reticularis)
iv. Induction phase-35-50 mg/kg PO q.d. x 5-7 d
v. Maintenance phase-35-50 mg/kg PO divided twice per week
vi. 500 mg tablet size
vii. Compounded
viii. Include prednisone at 0.5 mg/kg – at least 2 doses
ix. "Danger signs"
1. Loss of appetite
2. Lethargy
3. Vomiting
4. Diarrhea
5. Just ain't right
x. Side Effects
1. Adrenal cortical destruction
a. Glucocorticoid-deficient addisonian
b. Full-blown addisonian
c. Often reversible
2. Liver toxicity
a. Often resolves once off Lysodren
b. Can't use Lysodren again
xi. Monitoring
1. After induction phase
2. ACTH-stimulation test
3. Cortisol within normal range
4. No stimulation with ACTH
5. Liver panel
6. Clinical signs
7. ACTH-stimulation
a. Cortrosyn 5 mcg/kg IV/IM
b. Cortisol before and 60-90 min after ACTH
c. Cortrosyn
i. 250 mcg vial
ii. Reconstitute and freeze for 6 months
d. Normal cortisol range: 1-4 mcg/dl
i. Pre 1-4 mcg/dl
ii. Post 1-4 mcg/dl
e. 4-6 months for ACTH-stim once stabilized
o. Trilostane: Adrenal Hormones
i. Compounded
ii. Vetoryl: Dechra
iii. 1.5-3 mg/kg bid
iv. Lower dose bid – more efficacious and safer
v. Send home prednisone at 0.5 mg/kg – at least 2 doses
vi. "Danger signs"
1. Loss of appetite
2. Lethargy
3. Vomiting
4. Diarrhea
5. Just ain't right
vii. Side Effects of Trilostane
1. Addisonian –Glucocorticoid or Glucocorticoids + mineralocorticoids
2. Adrenal necrosis
3. Adrenal glands enlarged and bumpy over time
viii. Elevations of 17 OH Progesterone
ix. Cortisone decreased
x. Monitoring-7-10 days after beginning
1. ACTH-stimulation test
2. 2-6 hours after trilostane given
3. Cortisol within normal range
4. No stimulation with ACTH
5. Na/K level
p. Trilostane Versus Lysodren in PDH
i. Both as efficacious
1. Control clinical signs
2. Longevity
ii. Cost; Both sold commercially
iii. Trilostane must be given every day
iv. No lysodren with liver disease
v. Trilostane: can become Addisonian even after stable longterm treatment
vi. Adrenal gland hyperplasia/metaplasia
q. Trilostane Versus Lysodren in Adrenal Tumors
i. No studies
ii. Operable-Lysodren to kill metastatic cells (?)
iii. Inoperable-Trilostane to control excess hormone levels
iv. Trilostane + Lysodren (?)
r. Trilostane Versus Lysodren Follow Up
i. Lysodren – usually fairly stable after induction phase
ii. Trilostane
1. Addison's months after treatment starts
2. Most animals need dose adjustments
s. Feline Hyperadrenocorticism - Trilostane at 5 mg bid; NO LYSODREN
t. Deprenyl (anipryl) and ketoconazole